- Investor Relations
Medios AG is one of the best-known companies in the growth market of specialty pharmaceuticals in Germany.
Specialty pharma medicinal products are medicines for patients with rare or chronic diseases such as cancer, HIV, hepatitis or hemophilia.
Our work centers on patient wellbeing.
Medios AG is Germany's first specialty pharmaceutical company to be listed on the stock exchange.
Contact
Claudia Nickolaus
Head of Investor & Public Relations
ESG Communications
+49 30 232 566 800
Stay informed Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.
Registration is free of charge and can be revoked at any time.